Mr. Amit Agarwal

Co-Founder & Director – Aries Drugs Pvt. Ltd.

Overview

Mr. Amit Agarwal is the Managing Director and a founding force behind Aries Drugs Pvt. Ltd., a rapidly growing pharmaceutical contract manufacturing company established in 2005. With over 15 years of deep-rooted experience in pharmaceutical manufacturing and business development, Mr. Agarwal has been instrumental in shaping the company’s strategic vision, infrastructure, and product innovation.

He combines his technical expertise with a clear market-focused mindset to drive Aries Drugs toward operational excellence, regulatory compliance, and sustainable growth in the highly competitive Indian pharmaceutical landscape.

Industry Experience & Expertise

Mr. Agarwal brings a diverse and hands-on background in:

Regulatory Compliance & Infrastructure Development: Played a key role in setting up Aries Drugs’ WHO-GMP compliant manufacturing facility in Uttarakhand (operational since 2009), aligned with CGMP and DCGI norms
Contract Manufacturing & B2B Solutions: Expertise in providing third-party and private label services for pharmaceutical brands across India

His strong operational leadership has enabled Aries Drugs to become a trusted partner for pharma companies seeking quality, reliability, and scalability in manufacturing.

Leadership Philosophy

Mr. Agarwal believes in leading by innovation, integrity, and impact. His core leadership values include:

Maintaining quality-first culture across all production and distribution stages
Fostering long-term partnerships built on trust, transparency, and performance
Driving technology adoption and modernization to keep Aries Drugs ahead in compliance and efficiency

Strategic Contributions

Under Mr. Agarwal’s direction, Aries Drugs Pvt. Ltd. has:

Expanded its product portfolio to include high-demand therapeutic segments of non-betalactum preparations.
Created a robust third-party manufacturing ecosystem that supports small, mid, and large-scale pharmaceutical marketing firms
Strengthened the company’s footprint across the Indian subcontinent by delivering cost-effective and high-quality formulations

Vision for the Future

Mr. Agarwal continues to steer Aries Drugs with a forward-looking vision:

Establish new manufacturing units in other Indian states to increase capacity and geographic reach
Achieve entry into global pharmaceutical exports by 2030
Invest in automation, plant upgrades, and digital transformation for enhanced manufacturing efficiencies

Message from the Director

“At Aries Drugs, our strength lies in our people, our process, and our promise to deliver nothing less than excellence. We are not just manufacturing medicines — we are building trust with every dose, every product, and every partner we serve.”